Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,317,620 papers from all fields of science
Search
Sign In
Create Free Account
darodipine
Known as:
3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, diethyl ester
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Calcium Channel Blockers
Nifedipine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Testing of anti-atherogenic drugs and food components on cell cultures: assessment of reliability.
Sergei V. Jargin
Puerto Rico Health Sciences Journal
2010
Corpus ID: 32355329
In the large series of publications started in 1986 (The Lancet, 2:595), and continuing until today, was reported that culturing…
Expand
1997
1997
Protective effect of darodipine, a calcium antagonist, on rat cardiomyocytes against oxygen radical‐mediated injury
R. Matucci
,
M. Francesca Ottaviani
,
M. Barbieri
,
E. Cerbai
,
A. Mugelli
British Journal of Pharmacology
1997
Corpus ID: 25219919
1 We used electrophysiological and electron spin resonance (e.s.r.) techniques to study the mechanism of the protective effect of…
Expand
1995
1995
Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats.
G. Colombo
,
R. Agabio
,
+4 authors
G. Gessa
Alcohol and Alcoholism
1995
Corpus ID: 44316069
The effect of the dihydropyridine calcium channel antagonist, darodipine, on ethanol withdrawal syndrome was examined in rats…
Expand
1991
1991
The Preparation and Acute Antihypertensive Effects of a Nanocapsular Form of Darodipine, a Dihydropyridine Calcium Entry Blocker
B. Hubert
,
J. Atkinson
,
M. Guerret
,
M. Hoffman
,
J. Devissaguet
,
P. Maincent
Pharmaceutical Research
1991
Corpus ID: 1762484
We have addressed two problems associated with the use of dihydropyridine calcium entry blockers in antihypertensive therapy…
Expand
1989
1989
Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.
J. Pinquier
,
S. Urien
,
P. Chaumet‐Riffaud
,
J. Tillement
British Journal of Clinical Pharmacology
1989
Corpus ID: 26490501
1. Serum protein binding of isradipine and darodipine, and serum concentrations of alpha 1-acid glycoprotein (AAG), albumin (HSA…
Expand
1988
1988
Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes.
J. Pinquier
,
S. Urien
,
M. Lemaire
,
P. Chaumet‐Riffaud
,
J. Tillement
Pharmacology
1988
Corpus ID: 46852191
The binding of the two drugs isradipine and darodipine, chemically related to dihydropyridines and potent calcium channel…
Expand
1988
1988
Monotherapy of hypertension with darodipine: A new calcium‐channel blocker
M.D.. Ph. s. G . CHRYSANT
,
M. D. Chrysant
,
M. D. J. TRUS
,
A. Hitchcock
Clinical Cardiology
1988
Corpus ID: 35859686
Calcium‐channel blockers are increasingly used as single agents for the treatment of essential hypertension. Following three…
Expand
1988
1988
Inhibition of Glucose‐induced Insulin Secretion by Calcium Channel Blocking Drugs In‐vitro but not In‐vivo in the Rat
C. Semple
,
Maureen Smith
,
B. Furman
The Journal of pharmacy and pharmacology
1988
Corpus ID: 20375274
Abstract— The organic calcium channel blocking drugs darodipine, nicardipine, diltiazem and verapamil inhibited glucose‐induced…
Expand
1987
1987
Vasopressin increases 45Ca2+ influx in rat aortic smooth muscle cells.
A. Wallnöfer
,
C. Cauvin
,
U. Rüegg
Biochemical and Biophysical Research…
1987
Corpus ID: 37280418
1986
1986
Vasopressin induced myocardial depression is neurally mediated and not due to impaired coronary blood flow
R. Hof
British Journal of Pharmacology
1986
Corpus ID: 28501849
1 The mechanism of the cardiodepressant effect of vasopressin was studied by measuring simultaneously myocardial contractile…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE